References
- Kim ET, Kim LH, Lee JI, Chin HS. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin. Jpn J Ophthalmol 2009;53:598–602.
- Okuse C, Yotsuyanagi H, Nagase Y, Kobayashi Y, Yasuda K, Koike K et al. Risk factors for retinopathy associated with interferon α-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2006;12:3756–3759.
- Jain K, Lam WC, Waheeb S, Thai Q, Heathcote J. Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. Br J Ophthalmol 2001;85:1171–1173.
- Poynard T, Ratziu V, Benmanov Y, Di Martino V, Bedossa P, Opolon P. Fibrosis in patients with chronic hepatitis C: Detection and significance. Semin Liver Dis 2000;20:47–55.
- Kurosaki M, Tanaka Y, Nishida N, Sakamoto N, Enomoto N, Honda M et al. Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors. J Hepatol 2011;54:439–448.
- Newell FW. Ophthalmology: Principles and concepts, 6th Edition. St. Louis: The C. V. Mosby Company Ltd; 1986. pp 319–325.
- Nadir A, Amin A, Chalisa N, van Thiel DH. Retinal vein thrombosis associated with chronic hepatitis C: A case series and review of the literature. J Viral Hepat 2000;7:466–470.
- Rubio JE Jr, Charles S. Interferon-associated combined branch retinal artery and central retinal vein obstruction. Retina (Philadelphia, Pa) 2003;23:546–548.
- Nicolò M, Artioli S, La Mattina GC, Ghiglione D, Calabria G. Branch retinal artery occlusion combined with branch retinal vein occlusion in a patient with hepatitis C treated with interferon and ribavirin. Eur J Ophthalmol 2005;15:811–814.
- Zandieh I, Adenwalla M, Cheong-Lee C, Ma PE, Yoshida EM. Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C. World J Gastroenterol 2006;12:4908–4910.
- Goncalves LL, Farias AQ, Gonçalves PL, D’Amico EA, Carrilho FJ. Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C. World J Gastroenterol 2006;12:4602–4603.
- Sene D, Touitou V, Bodaghi B, Saadoun D, Perlemuter G, Cassoux N et al. Intraocular complications of IFN-α and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol 2007;13:3137–3140.
- Murata M, Tamura Y, Ohsawa M, Hirano T, Matsuo T, Murata T. Central retinal vein occlusion in hypertensive patients with chronic hepatitis C treated with interferon α and ribavirin. Jpn J Ophthalmol 2008;52:511–513.
- Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P et al.; International Eye Disease Consortium. The prevalence of retinal vein occlusion: Pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010;117:313–9.e1.
- Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis 2002;22:83–96.